Pilot Trial: Bioavailability Animal vs. Plant Protein Drink
NCT ID: NCT06465004
Last Updated: 2024-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
12 participants
INTERVENTIONAL
2024-06-08
2024-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will involve approximately 12 healthy adults aged 18-40. Each participant will try all three drinks (the new plant-based drink, a commercial animal-based drink, and another animal-based recipe) on separate days in a randomized order. Before and after (30, 60, and 90 minutes) consuming each drink, a small blood sample will be drawn to measure amino acid levels (leucine).
By comparing the results, the investigators hope to determine if the plant-based drink can match the effectiveness of animal-based protein drinks in delivering essential nutrients. This research could contribute to the development of sustainable and nutritious plant-based protein alternatives.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Novel Blend of Plant Protein and Additional Ingredients on Resistance Training Adaptations
NCT06908811
Modulation of Muscle Protein Synthesis With Diet and Exercise in Old Aged Women
NCT02053441
How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses
NCT07121010
Aminoacidemia and Protein Kinetics in Response to the Ingestion of Plant-based Protein Blends
NCT05139160
Bioavailability of Plant Protein Amino Acids
NCT04872530
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Animal-based A
A commercially available high protein drink, based on animal proteins (Fresubin Protein Energy)
Consumption of protein - rich drink
The participants will drink on of three protein - rich drinks
Animal-based B
A homemade drink containing animal-based proteins, using a specific animal-based protein isolate mix.
Consumption of protein - rich drink
The participants will drink on of three protein - rich drinks
Plant-based A
A homemade drink containing plant-based proteins, formulated to have the same macronutrient content as the animal-based drinks.
Consumption of protein - rich drink
The participants will drink on of three protein - rich drinks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Consumption of protein - rich drink
The participants will drink on of three protein - rich drinks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 18-40 years
* Signed written informed consent
Exclusion Criteria
* Cardiovascular diseases
* BMI \> 35 kg/m2
* Caffeine consumption \< 1 day before the study participation
* Allergies: Soy, Peas, Milk, Lactose, Fructose
* High intensity exercise \<2 days before study participation
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ETH Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gommaar D'Hulst, PhD
Role: PRINCIPAL_INVESTIGATOR
ETH Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SLA - ETH Zurich
Schwerzenbach, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-00151
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.